Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection

British Journal of Haematology

Volumn 171, Issue 5, 2015, Pages 887-890

  Parry, Helen M ^a   Birtwistle, Jane ^a   Whitelegg, Alison ^a   Hudson, Chris ^b   Mcskeane, Tina ^a   Hazlewood, Peter ^a   Mudongo, Nyasha ^c   Pratt, Guy ^a   Moss, Paul ^a   Drayson, Mark T ^a   Murray, Jim ^d   Richter, Alex G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Immunodeficiency; Infection

Indexed keywords

IMMUNOGLOBULIN G; PNEUMOCOCCUS VACCINE; ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTECTION; WATCHFUL WAITING; ANTIBODY PRODUCTION; IMMUNOLOGY; INFECTION; METABOLISM; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIBODY FORMATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; RISK FACTORS;

EID: 84955361357     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13455     Document Type: Article

References (10)

1. Ben-Bassat, I., Many, A., Modan, M., Peretz, C. & Ramot, B. (1979) Serum immunoglobulins in chronic lymphocytic leukemia. American Journal of the Medical Sciences, 278, 4-9.
2. Hamblin, A.D. & Hamblin, T.J. (2008) The immunodeficiency of chronic lymphocytic leukaemia. British Medical Bulletin, 87, 49-62.
3. Jackson, L.A., Neuzil, K.M., Nahm, M.H., Whitney, C.G., Yu, O., Nelson, J.C., Starkovich, P.T., Dunstan, M., Carste, B., Shay, D.K., Baggs, J. & Carlone, G.M. (2007) Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine, 25, 4029-4037.
4. Jodar, L., Butler, J., Carlone, G., Dagan, R., Goldblatt, D., Kayhty, H., Klugman, K., Plikaytis, B., Siber, G., Kohberger, R., Chang, I. & Cherian, T. (2003) Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine, 21, 3265-3272.
5. Lu, C.L., Chang, S.Y., Chuang, Y.C., Liu, W.C., Su, C.T., Su, Y.C., Chang, S.F. & Hung, C.C. (2014) Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy. Vaccine, 32, 1031-1035.
6. Oscier, D., Dearden, C., Eren, E., Fegan, C., Follows, G., Hillmen, P., Illidge, T., Matutes, E., Milligan, D.W., Pettitt, A., Schuh, A. & Wimperis, J. (2012) Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. British Journal of Haematology, 159, 541-564.
7. Phillips, A.C., Carroll, D., Burns, V.E., Ring, C., Macleod, J. & Drayson, M. (2006) Bereavement and marriage are associated with antibody response to influenza vaccination in the elderly. Brain, Behavior, and Immunity, 20, 279-289.
8. Rennels, M.B., Edwards, K.M., Keyserling, H.L., Reisinger, K.S., Hogerman, D.A., Madore, D.V., Chang, I., Paradiso, P.R., Malinoski, F.J. & Kimura, A. (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics, 101, 604-611.
9. Sinisalo, M., Vilpo, J., Itala, M., Vakevainen, M., Taurio, J. & Aittoniemi, J. (2007) Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine, 26, 82-87.
10. Thurmes, P., Call, T., Slager, S., Zent, C., Jenkins, G., Schwager, S., Bowen, D., Kay, N. & Shanafelt, T. (2008) Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leukaemia & Lymphoma, 49, 49-56.